Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gliosarcoma × Tetanus Toxoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Glioblastoma 3 Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Glioma 2 Whooping Cough 1 Sarcoma 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumococcal Infections 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasms, Plasma Cell 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Measles 1 Lymphoma, Non-Hodgkin 1 Lipodystrophy, Congenital Generalized 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Human Papillomavirus-Related Cervical Carcinoma 1 Hodgkin Disease 1 Hepatitis B 1 HIV Infections 1 Gliosarcoma 1 Colorectal Neoplasms 1

Interventions

Temozolomide 123 Radiotherapy 82 Bevacizumab 41 Radiation 30 Carmustine 26 Irinotecan 21 Erlotinib Hydrochloride 21 Magnetic Resonance Spectroscopy 19 Chemotherapy, Adjuvant 17 Surgical Procedures, Operative 13 O(6)-benzylguanine 13 Carboplatin 13 sargramostim 12 Radiotherapy, Intensity-Modulated 11 Radiotherapy, Conformal 11 Imatinib Mesylate 9 Thalidomide 8 Drug Therapy 8 motexafin gadolinium 7 Radiosurgery 7 Procarbazine 7 Gene Expression Profiling 7 Gefitinib 7 Filgrastim 7 Cyclophosphamide 7 pembrolizumab 6 cediranib 6 Vorinostat 6 Sirolimus 6 Lomustine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00639639 2023-03-13

ATTAC

Duke University

Phase 1 Completed

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡